Author: Bruce B Lee1, Steve P Yu2
1 Santa Monica-UCLA Medical Center, 1250 16th Street, Santa Monica, CA 90404 USA ; Roxbury Clinic and Surgery Center, 465 N Roxbury Dr. #1001, Beverly Hills, CA 90210 USA ; Ventura Surgery Center, 1752 S Victoria Ave #A, Ventura, CA 93003 USA ; Division of Minimally Invasive Surgery, Department of OBGYN, University of California|, Los Angeles, CA USA.
2 Division of Minimally Invasive Surgery, Department of OBGYN, University of California|, Los Angeles, CA USA.
Conference/Journal: Curr Obstet Gynecol Rep
Date published: 2016
Other: Volume ID: 5 , Issue ID: 4 , Pages: 318-324 , Special Notes: doi: 10.1007/s13669-016-0183-x. , Word Count: 119
Laparoscopic, ultrasound-guided radiofrequency ablation (RFA) is a new, FDA-cleared uterine sparing, outpatient procedure for uterine fibroids. The procedure utilizes recent technological advancements in instrumentation and imaging, allowing surgeons to treat numerous fibroids of varying size and location in a minimally invasive fashion. Early and mid-term data from multi-center clinical trials have demonstrated safety and efficacy, with resolution or improvement of symptoms and significant volume reduction. Re-intervention rates for fibroid symptoms have been low. The procedure is well tolerated with a typically uneventful and rapid recovery requiring NSAIDs only for postoperative pain. While post RFA pregnancy data are limited, the results are promising.
Keywords: Laparoscopy; Minimally invasive surgery; Radiofrequency ablation; Uterine fibroids.
PMID: 27917310 PMCID: PMC5114324 DOI: 10.1007/s13669-016-0183-x